Home > Financial Ratios > NURECA

NURECA
Core EBITDA Growth

    Back to All Ratios
NURECA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NURECA
Please provide your vote to see the results

NURECA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 69.111,494.46103.88-112.51-1.79

What is the latest Core EBITDA Growth ratio of NURECA ?

The latest Core EBITDA Growth ratio of NURECA is 69.11 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202669.11
Mar20251,494.46
Mar2024103.88
Mar2023-112.51
Mar2022-1.79

How is Core EBITDA Growth of NURECA Trending?

Years Core EBITDA Growth % Change
Mar2026 69.11
-95.38
Mar2025 1494.46
1,338.64
Mar2024 103.88
Positive
Mar2023 -112.51
Negative
Mar2022 -1.79 -

Other Financial Ratios of NURECA


Compare Core EBITDA Growth ratio of peers of NURECA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NURECA ₹286.6 Cr -0.8% -12.8% 17.5% Stock Analytics
LENSKART SOLUTIONS ₹120,186.0 Cr 1.3% -0.1% NA Stock Analytics
POLY MEDICURE ₹16,092.7 Cr 8.5% -1.8% -24% Stock Analytics
3B BLACKBIO DX ₹1,141.7 Cr -2.2% -18.4% -1.7% Stock Analytics
LAXMI DENTAL ₹1,036.2 Cr 5.7% -1.1% -41.9% Stock Analytics
PREVEST DENPRO ₹480.1 Cr 5.2% 5.1% -26.4% Stock Analytics


NURECA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NURECA

-0.8%

-12.8%

17.5%

SENSEX

5.5%

7.5%

-8.7%


You may also like the below Video Courses